Department of Thoracic Surgery, University Medical Center Regensburg, Regensburg, Germany.
Department of Thoracic Surgery, Hospital Barmherzige Brüder Regensburg, Regensburg, Germany.
Thorac Cancer. 2022 Aug;13(15):2158-2163. doi: 10.1111/1759-7714.14534. Epub 2022 Jun 15.
The objective of this nationwide, registry-based study was to compare the two most frequently used procedures for the palliative treatment of a malignant pleural effusion (MPE) and to evaluate differentiated indications for these two procedures.
This was a retrospective observational study based on data of the "PLEURATUMOR" registry of the German Society for Thoracic Surgery. Patients who were documented in the period from January 2015 to November 2021 and had video-assisted thoracic surgery (VATS) talc pleurodesis or implantation of an indwelling pleural catheter (IPC) were included.
A total of 543 patients were evaluated. The majority suffered from secondary pleural carcinomatosis (n = 402; 74%). VATS talc pleurodesis (n = 361; 66.5%) was performed about twice as often as IPC implantation (n = 182; 33.5%). The duration of surgery was significantly shorter in IPC-patients with 30 min compared to VATS talc pleurodesis (38 min; p = 0.000). Postoperative complication rate was 11.8% overall and slightly higher after VATS talc pleurodesis (n = 49; 13.6%) than after IPC implantation (n = 15; 8.2%). After VATS talc pleurodesis patients were hospitalized significantly longer compared to the IPC group (6 vs. 3.5 days; p = 0.000). There was no significant difference in postoperative wound infections between the groups (p = 0.10). The 30-day mortality was 7.9% (n = 41).
The implantation of an IPC can significantly shorten the duration of surgery and the hospital stay. For this reason, the procedure should be matched with the patient's expectations preoperatively and the use of an IPC should be considered not only in the case of a trapped lung.
本项全国性基于登记的研究旨在比较两种最常用于恶性胸腔积液(MPE)姑息性治疗的方法,并评估这两种方法的不同适应证。
这是一项基于德国胸外科协会“PLEURATUMOR”登记处数据的回顾性观察性研究。纳入 2015 年 1 月至 2021 年 11 月期间接受电视辅助胸腔镜手术(VATS)滑石胸膜固定术或留置胸膜导管(IPC)植入术的患者。
共评估了 543 例患者。大多数患者患有继发性胸膜癌(n=402;74%)。VATS 滑石胸膜固定术(n=361;66.5%)的实施频率约为 IPC 植入术(n=182;33.5%)的两倍。IPC 患者的手术时间明显短于 VATS 滑石胸膜固定术患者(30 分钟 vs. 38 分钟;p=0.000)。总的术后并发症发生率为 11.8%,VATS 滑石胸膜固定术患者(n=49;13.6%)略高于 IPC 植入术患者(n=15;8.2%)。VATS 滑石胸膜固定术后患者的住院时间明显长于 IPC 组(6 天 vs. 3.5 天;p=0.000)。两组间术后伤口感染无显著差异(p=0.10)。30 天死亡率为 7.9%(n=41)。
IPC 植入术可显著缩短手术时间和住院时间。因此,术前应根据患者的预期进行匹配,并考虑在肺部塌陷的情况下使用 IPC。